Jaafar El-Annan, MD

  • 841 Citations
  • 11 h-Index
20042023
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jaafar El-Annan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 0 Similar Profiles
Eye Diseases Medicine & Life Sciences
Diabetic Retinopathy Medicine & Life Sciences
Visual Acuity Medicine & Life Sciences
Lebanon Medicine & Life Sciences
Retinal Pigment Epithelium Medicine & Life Sciences
Fluorescein Angiography Medicine & Life Sciences
Optical Coherence Tomography Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2023

Research Output 2004 2019

  • 841 Citations
  • 11 h-Index
  • 26 Article
  • 1 Comment/debate
  • 1 Letter
1 Citation (Scopus)

Adverse reactions to fluorescein angiography: A comprehensive review of the literature

Kornblau, I. S. & El-Annan, J., Jan 1 2019, In : Survey of Ophthalmology.

Research output: Contribution to journalArticle

Fluorescein Angiography
Fluorescein
Hypersensitivity
PubMed
Injections

Development of focal choroidal excavation in non-neovascular age related macular degeneration with pachy-choroid features

Banaee, T., Lyons, L. J. & El-Annan, J., Jan 1 2019, (Accepted/In press) In : Journal of Current Ophthalmology.

Research output: Contribution to journalArticle

Open Access
Choroid
Optical Coherence Tomography
Macular Degeneration
Thrombosis
Software

Corrigendum to: Five-Year Incidence and Progression of Diabetic Retinopathy in Patients with Type II Diabetes in a Tertiary Care Center in Lebanon(Ophthalmology (2017) 2017 (9805145) DOI: 10.1155/2017/9805145)

Mehanna, C. J., Fattah, M. A., Tamim, H., Nasrallah, M. P., Zreik, R., Haddad, S. S., El-Annan, J., Raad, S., Haddad, R. S. & Salti, H. I. S., Jan 1 2018, In : Journal of Ophthalmology. 2018, 2424757.

Research output: Contribution to journalComment/debate

Lebanon
Diabetic Retinopathy
Ophthalmology
Tertiary Care Centers
Type 2 Diabetes Mellitus

Low-dose rifampin as maintenance therapy in chronic central serous chorioretinopathy

Mattingly, J. J., Amram, A. L. & El-Annan, J., Jan 1 2018, (Accepted/In press) In : Canadian Journal of Ophthalmology.

Research output: Contribution to journalArticle

Central Serous Chorioretinopathy
Rifampin
Therapeutics

Retinal pigment epithelium tears in a 67-year-old man

Sultan, H., Kellogg, C. & El-Annan, J., May 1 2018, In : JAMA Ophthalmology. 136, 5, p. 583-584 2 p.

Research output: Contribution to journalArticle

Retinal Pigment Epithelium